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Lipocalin-type prostaglandin D synthase (L-PGDS) catalyzes the 
isomerisation of the 9,11-endoperoxide group of PGH2 (Prostaglandin H2) to 
produce PGD2 (Prostaglandin D2) with 9-hydroxy and 11-keto groups in the 
presence of sulphydryl compounds. PGH2 is a common precursor of all 
prostanoids, which include thromboxanes, prostacyclins and prostaglandins. 
PGD2 is synthesized in both the central and peripheral nervous system and it is 
involved in many regulatory events. L-PGDS, the first member of the important 
lipocalin family to be recognized as an enzyme, is also able to bind and transport 
small hydrophobic molecules and was formerly known as β-trace protein, the 
second most abundant protein in human cerebro-spinal fluid. L-PGDS is also 
detected in brain, testis and prostate, endothelial cells, placenta and heart tissue 
and even in macrophages infiltrated in atherosclerotic plaques. In these tissues it 
participates in many physiological activities as well as in the response to 
diseases. In this work we use recombinant human L-PGDS in order to solve its 
three-dimensional structure by X-ray diffraction and test its affinity for several 
ligands using Surface Plasmon Resonance (SPR). Wild type human L-PGDS and 
three mutants (C65A; C65A-K59A; C89/186A) were expressed using E. coli cell 
strains and subsequently purified by a chitin affinity column, size exclusion and 
hydrophobic interaction chromatography. Large and highly ordered crystals were 
used to collect X-ray diffraction data using either a rotating-anode generator or a 
synchrotron source. The multiple isomorphous replacement method was used to 
solve the phase problem. In the electron density maps an unidentified density 
was observed apparently interacting with lysine 59 inside the L-PGDS-C65A 
cavity; the foreign molecule could be PEG, an additive present in the 
crystallization liquors. This hypothesis is supported by the fact that the L-PGDS-
C65A/K59A crystals, which grow without PEG, show a completely free protein 
cavity. A seeding experiment of L-PGDS-C65A/K59A crystal, grown in L-
PGDS-C65A crystallization conditions, partially confirmed this hypothesis since 
the foreign molecule was present in the L-PGDS-C65A/K59A cavity. Another 
molecule that can explain this foreign density is triacontyl acetate, that can be 
present in the Luria Bertani medium used to growth E. coli cells. We are 
currently trying to establish the identity of the unknown ligand. Another crystal 
form was obtained by mixing L-PGDS-C65A/K59A with the amyloid β peptide 
(1-40). Although the amyloid β peptide is not visible in the maps, the packing of 
the protein molecules was changed in the presence of the peptide suggesting 
interaction of the two molecules. Wild type L-PGDS small crystals were recently 
obtained and will be tested as soon as synchrotron beam time becomes available. 
